MedTrace Logo

Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment

NCT03088553 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2023-04-12

No results posted yet for this study

Summary

This study aims to better define the target range of ganciclovir trough concentrations by investigating the relationship between ganciclovir concentration and the time to undetectable CMV-DNA load, in preemptive and curative treatments by (val)ganciclovir.

Conditions

  • Solid Organ Transplantation

Interventions

DRUG

Therapeutic Drug Monitoring

Trough concentration of ganciclovir and viral load measurement at each follow-up visit.

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2023-12-21
Completion
2024-06-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03088553 on ClinicalTrials.gov